• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A role and progress process of DAMPs with intractable central nerve infectious disease

Research Project

Project/Area Number 26461590
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Pediatrics
Research InstitutionFukushima Medical University

Principal Investigator

Suyama Kazuhide  福島県立医科大学, 医学部, 講師 (90423798)

Co-Investigator(Kenkyū-buntansha) 川崎 幸彦  福島県立医科大学, 医学部, 准教授 (00305369)
橋本 浩一  福島県立医科大学, 医学部, 准教授 (50322342)
佐藤 晶論  福島県立医科大学, 医学部, 講師 (60423795)
細矢 光亮  福島県立医科大学, 医学部, 教授 (80192318)
Project Period (FY) 2014-04-01 – 2017-03-31
Project Status Completed (Fiscal Year 2016)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsDAMPs / HMGB1 / 脳炎脳症 / バイオマーカー / HUSマウス / S100A8 / S100A9 / S100A12 / 脳炎 / 脳症
Outline of Final Research Achievements

I examined an epidemiological clinical characteristic of Fukushima of the acute encephalitis and encephalopathy and a factor in conjunction with the convalescence to examine a role of DAMPs in the onset, the progress mechanism of the central nerve infectious disease. Disturbance of consciousness and respiratory failure were bad prognosis.
I made some seriously HUS model mouse. Serum HMGB1 level in seriously HUS mouse ware highest at 6hr and decreased 48hr. So participation of DAMPs was suggested for progress mechanism of the HUS. I searched the inflammatory protein using a cerebrospinal fluid specimen at human acute encephalitis and acute encephalopathy onset. Alpha2 macroglobulin in cerebrospinal fluid increased with the acute disseminated encephalomyelitis, and possibility of acute encephalopathy early biomarker was suggested.

Report

(4 results)
  • 2016 Annual Research Report   Final Research Report ( PDF )
  • 2015 Research-status Report
  • 2014 Research-status Report
  • Research Products

    (4 results)

All 2016 2014

All Journal Article (3 results) (of which Peer Reviewed: 3 results,  Open Access: 1 results) Presentation (1 results)

  • [Journal Article] Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis.2016

    • Author(s)
      Kazuhide Suyama
    • Journal Title

      Pediatric International

      Volume: 58 Pages: 219-223

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.2016

    • Author(s)
      陶山 和秀
    • Journal Title

      nephrol Dial Transplant

      Volume: 6 Issue: 6 Pages: 969-977

    • DOI

      10.1093/ndt/gfv004

    • Related Report
      2015 Research-status Report
    • Peer Reviewed
  • [Journal Article] Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan2014

    • Author(s)
      Kawasaki Y, Suyama K, Maeda R, Yugeta E, Takano K, Suzuki S, Sakuma H, Nemoto K, Sato T, Nagasawa K, Hosoya M
    • Journal Title

      Pediatr. Int

      Volume: Vol.56、No.1 Issue: 1 Pages: 77-82

    • DOI

      10.1111/ped.12193

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 福島県過去26年間における小児期発症急性脳症脳炎260例の検討2014

    • Author(s)
      川崎 幸彦, 陶山 和秀
    • Organizer
      日本小児感染症学会
    • Place of Presentation
      東京都
    • Year and Date
      2014-10-19
    • Related Report
      2014 Research-status Report

URL: 

Published: 2014-04-04   Modified: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi